IXC and NXR added.


First up with have biopharmaceutical provider Invex Therapeutics (IXC) who are developing “treatments for neurological conditions derived from or involving raised intracranial pressure”. The prosectus delves a little deeper, but you may need a thesaurus handy.

The 25M shares on offer will be priced at 40 cents each as the company looks to raise 10M, a successful completion will see Market Cap at 20M. Get all the details in the prospectus here.


If you’re looking for something a little more traditional then Nemex Resources may be more your style. “Nemex is a junior exploration company with a conditional right to acquire mineral exploration projects prospective for gold and base metals located in Western Australia”.

20 cents will buy you one of over 25M shares on offer with a full raise seeing around 5M flowing in, market cap will be a bit over 10M on completion. Prospectus can be found here.